BeOne Medicines Ltd. — Director's Dealing 2023

Mar 11, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2023-03-08

Reporting Person: Wang Xiaodong (Director, Chair, Scientific Advisory Brd)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-08	American Depositary Shares	M	67635	$0.13	Acquired	67635	Direct
2023-03-08	American Depositary Shares	S	3433	$222.9985	Disposed	64202	Direct
2023-03-08	American Depositary Shares	S	7458	$224.0088	Disposed	56744	Direct
2023-03-08	American Depositary Shares	S	12534	$224.9239	Disposed	44210	Direct
2023-03-08	American Depositary Shares	S	400	$225.3475	Disposed	43810	Direct
2023-03-08	American Depositary Shares	S	200	$226.6109	Disposed	43610	Direct
2023-03-08	American Depositary Shares	S	14077	$225.9541	Disposed	29533	Direct
2023-03-08	American Depositary Shares	S	17170	$227.1205	Disposed	12363	Direct
2023-03-08	American Depositary Shares	S	12363	$227.7809	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-08	Share Option (Right to Buy)	$0.01	M	879255	Disposed	2023-04-03	Ordinary Shares (879255.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	5512556	Direct
Ordinary Shares	1127542	Indirect
Ordinary Shares	172372	Indirect
Ordinary Shares	4058998	Indirect
Ordinary Shares	50	Indirect

Footnotes

F1: These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.

F2: These securities are held in a UTMA account for the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.

F3: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.

F4: These securities are held by the spouse of the Reporting Person.

F5: Each American Depositary Share represents 13 Ordinary Shares.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.47 to $223.44, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.47 to $224.46, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.48 to $225.45, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.87 to $225.51, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.2218 to $227.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.50 to $226.49, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.50 to $227.49, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.50 to $228.15, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F14: These securities vest over a five-year period as follows: 20% on April 3, 2014, and the remaining in 48 successive equal monthly installments, subject to continued service.